NCT02995005View on ClinicalTrials.gov

Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

May 24, 2018

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Hepatitis B
Interventions
DRUG

Tenofovir Disoproxil Fumarate

300 mg daily

Trial Locations (1)

Unknown

Shoklo Malaria Research Unit, Mae Sot

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

collaborator

Shoklo Malaria Research Unit

OTHER

collaborator

Chiang Mai University

OTHER

collaborator

University of Oxford

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT02995005 - Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus | Biotech Hunter | Biotech Hunter